Multiple studies have shown that most patients who receive chimeric antigen receptor (CAR) T-cell therapy report a good quality of life long-term. Learn how CAR T-cell therapy is performed and its short-term and long-term effects on patients and caregivers. Discover key differences between CAR T-cell, stem cell transplant and other and chemotherapy treatments.

Advanced age has traditionally been seen as prohibitive for treatments like stem cell transplants and CAR T therapy. This presentation reviews evidence that overall fitness is a crucial factor in reducing non-relapse mortality and that otherwise healthy elderly patients can have successful outcomes after transplant and CAR T-cell therapy.

Presentado por el Dr. Morris Kletzel, Hospital de Niños Ann & Robert H. Lurie de Chicago Tiempo de ejecución: 23 minutos El Dr. Kletzel disertará sobre: enfermedades tratadas con trasplante

Presentado por Hugo Fernández MD, Centro de Cáncer e Instituto de Investigación Moffitt Tiempo de ejecución: 20 minutos El Dr. Fernandez disertará sobre: lo que involucra llevar a cabo un

After being diagnosed with myelodysplastic syndrome, nurse Justin Regan underwent two stem cell transplants using cells from a donor. He recounts his experience and shares what inspired him to continue on through treatment, despite the difficulties.

Download Speaker Slides Transplant and CAR T-cell Therapy in Older Adults Sunday, April 30, 2023 Presenter: Richard Lin MD, PhD, Memorial Sloan Kettering Cancer Center Presentation is 35 minutes long

CAR T-cell therapy is a new treatment option for patients with acute lymphoblastic leukemia, some lymphomas, and multiple myeloma that have not responded to prior therapies. This presentation describes how CAR T-cell therapy works, its risks and side effects, and how these may be effectively managed.

CAR T-cell therapy is new treatment option for patients with certain types of non-Hodgkin lymphoma, acute lymphoblastic leukemia and multiple myeloma who relapsed or did not respond to other treatments. This presentation discusses who is eligible to receive CAR T-cell therapy, what the procedure entails and potential side effects.

CAR T-cell therapy is a new type of immunotherapy that’s been approved by the FDA to treat patients with certain types of leukemia and lymphoma. Some patients have lived more than 10 years after treatment.

This short animated video explains what to expect when undergoing an autologous stem cell transplant.